Continuous Piperacillin-Tazobactam Infusion Improves Clinical Outcomes in Critically Ill Patients with Sepsis: A Retrospective, Single-Centre Study

Continuous infusion of beta-lactam antibiotics has emerged as an alternative for the treatment of sepsis because of the favourable pharmacokinetics of continuous infusion. This study aimed to evaluate the survival benefits of continuous vs. intermittent infusion of piperacillin-tazobactam in critica...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Dong-gon, Seo, Jarim, Lee, Su Yeon, Ahn, Jee Hwan, Hong, Sang-Bum, Lim, Chae-Man, Koh, Younsuck, Huh, Jin Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686508/
https://www.ncbi.nlm.nih.gov/pubmed/36358163
http://dx.doi.org/10.3390/antibiotics11111508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686508/
https://www.ncbi.nlm.nih.gov/pubmed/36358163
http://dx.doi.org/10.3390/antibiotics11111508

Ejemplares similares